Antiphospholipid Antibody Syndrome

Obstetrics and Gynecology Clinics of North America

Volumn 41, Issue 1, 2014, Pages 113-132

  Kutteh, William H ^a,b   Hinote, Candace D ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Fertility Associates of Memphis   (United States)

^c MidSouth OB GYN   (United States)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Complications of pregnancy; Fetal demise; Recurrent pregnancy loss; Unfractionated heparin

Indexed keywords

ANTIPHOSPHOLIPID ANTIBODIES; ANTIPHOSPHOLIPID SYNDROME; COMPLICATIONS OF PREGNANCY; FETAL DEMISE; RECURRENT PREGNANCY LOSS; UNFRACTIONATED HEPARIN;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PLACENTAL INSUFFICIENCY; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84893344290     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2013.10.004     Document Type: Review

References (99)

1. DeWolf F., Carreras L.O., Moerman P., et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982, 142:829-834.
2. Adler R.R., Ng A.K., Rote N.S. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995, 53:905-910.
3. Katsuragawa H., Kanzaki H., Inoue T., et al. Monoclonal antibody against phosphatidylserine inhibits invitro human trophoblastic hormone production and invasion. Biol Reprod 1997, 56:50-58.
4. Quenby S., Mountfield S., Cartwright J.E., et al. Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005, 83:691-698.
5. Rand J.H. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002, 11:29-37.
6. Out H.J., Kooijman C.D., Bruinse H.W., et al. Histopathological findings in placentae from patients with intrauterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991, 41:179-186.
7. Kutteh W.H., Rote N.S., Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999, 41:133-152.
8. Schust D.J., Hill J.A. Recurrent pregnancy loss 2002, Lippincott Williams & Wilkins, Philadelphia.
9. Rand J.H. The antiphospholipid syndrome. Annu Rev Med 2003, 54:409-424.
10. Lockshin M.D. Antiphospholipid antibody. JAm Med Assoc 1997, 277:1549-1554.
11. Alarcón-Segovia D., Deleze M., Oria C.V., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989, 68:353-365.
12. Kutteh W.H., Lyda E.C., Abraham S.M., et al. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 1993, 60:449-499.
13. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). JThromb Haemost 2006, 4:295-306.
14. Harris E.N. Syndrome of the black swan. Br J Rheumatol 1986, 26:324-326.
15. Branch D.W., Holmgren C., Goldberg J.D. Antiphospholipid syndrome. American College of Obstetricians and Gynecologists Practice Bulletin Number 118. Obstet Gynecol 2012, 120:1514-1521.
16. Silver R.M., Draper M.L., Scott J.R., et al. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994, 83:372-377.
17. Martin B.A., Branch D.W., Rodgers G.M. Sensitivity of the activated partial thromboplastin time, the dilute Russell's viper venom time, and the Kaolin clotting time for the detection of the lupus anticoagulant: a direct comparison using plasma dilutions. Blood Coagul Fibrinolysis 1996, 7:31-38.
18. Pengo V., Tripodi A., Reber G., et al. Update on the guidelines for lupus anticoagulant detection. JThromb Haemost 2009, 7:1737-1740.
19. Harris E.W., Gharavi A.E., Boey M.L., et al. Anticardiolipin antibodies:detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 2:1211-1214.
20. Di Simone N., Meroni P.L., Del Papa N., et al. Antiphospholipid antibodies affecttrophoblast gonadotrophin secretion and invasiveness by binding directly and through adhered beta-2 glycoprotein-1. Arthritis Rheum 2000, 43:140-150.
21. McIntyre J. Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 1992, 28:127-131.
22. Schousboe I., Rasmussen M. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta-2 glycoprotein-1 and anti-beta-2 glycoprotein-1. Thromb Haemost 1995, 73:798-804.
23. Yetman D.L., Kutteh W.H. Antiphospholipid antibody panels and Recurrent Pregnancy Loss: Prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996, 66:540-546.
24. Franklin R.D., Kutteh W.H. Antiphospholipid antibodies (APA) and Recurrent Pregnancy Loss: Treating a unique APA positive population. Human Reprod 2002, 17:2981-2985.
25. Benedetto C., Marozio L., Tavella A.M., et al. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci 2010, 1205:106-117.
26. Hatasaka H.H. Recurrent miscarriage epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol 1994, 37:625-634.
27. Evaluation and treatment of Recurrent Pregnancy Loss. Fertil Steril 2012, 98:1103-1111. The Practice Committee of the American Society for Reproductive Medicine.
28. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two verses three or more recurrent pregnancy losses. Fertil Steril 2010, 93:1234-1243.
29. Allison J., Schust D. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes 2009, 16:446-450.
30. Vinatier D., Dufour P., Cosson M., et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 2001, 96:37-50.
31. Chaleur C., Galanaud J.P., Alonso S., et al. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. JThromb Haemost 2010, 8:699-706.
32. Oron G., Ben-Haroush A., Goldfarb R., et al. Contribution of the addition of anti-beta 2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome. JMatern Fetal Neonatal Med 2011, 24:606-609.
33. Abrahams V. Mechanisms of antiphospholipid antibody-associated pregnancy complications. Thromb Res 2009, 124:521-525.
34. Ziakas P.D., Pavlou M., Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010, 115:1256-1262.
35. Hoppe B., Burmester G.R., Dorner T. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome). Curr Opin Rheumatol 2011, 23:299-304.
36. Backos M., Rai R., Baxter N., et al. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999, 106:102-107.
37. Branch D.W., Khamashta M.A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003, 101:1333-1344.
38. Robertson L., Wu O., Langhorne P., for The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study, et al. Thrombophilia in pregnancy; a systematic review. Br J Haematol 2006, 132:171-196.
39. Alfirevic Z., Roberts D., Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcomeα A systematic review. Eur J Obstet Gynecol Reprod Biol 2002, 101:6-14.
40. Ruffatti A., Tonello M., Cavazzana A., et al. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009, 123:482-487.
41. Werner E., Lockwood C. Thrombophilias and stillbirth. Clin Obstet Gynecol 2010, 53:617-627.
42. Nodler J., Moolamalla S., Ledger E., et al. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 2009, 9:11-18.
43. do Prado A., Piovesan D., Staub H., et al. Association of anticardiolipin antibodies with pre-eclampsia. Obstet Gynecol 2010, 116:1433-1443.
44. Heilmann L., Schorsch M., Hahn T., et al. Antiphospholipid syndrome and pre-eclampsia. Semin Thromb Hemost 2011, 37:141-145.
45. Branch D.W., Silver R.M., Blackwell J.L., et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992, 80:614-620.
46. Cowchock F.S., Reece E.A., Balaban D., et al. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose aspirin treatment. Am J Obstet Gynecol 1992, 166:1318-1323.
47. Laskin C.A., Bombardier C., Hannah M.E., et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. NEngl J Med 1997, 337:148-153.
48. Kutteh W.H., Ermel L.D. Aclinical trial for the treatment of antiphospholipid antibody associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996, 35:402-407.
49. Empson M., Lassere M., Craig J.C., et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002, 99:135-144.
50. Lima F., Khamashta M.A., Buchanan N.M., et al. Astudy of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996, 14:131-136.
51. Yasuda M., Takakuwa K., Tokunage A., et al. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995, 86:555-559.
52. Motta M., Lachassinne E., Boffa M.C., et al. European registry of infants born to mothers with antiphospholipid syndrome: preliminary results. Minerva Pediatr 2010, 62(3 Suppl 1):25-27.
53. Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome. NEngl J Med 2002, 346:752-763.
54. Tincani A., Balestrieri G., Danieli E., et al. Pregnancy complications of the antiphospholipid syndrome. Autoimmunity 2003, 36:27-32.
55. Meroni P.L., Riboldi P. Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 2001, 13:377-382.
56. Branch D., Dudley D.J., Mitchell M.D., et al. Immunoglobulin G fraction from patients with antiphospholipid antibodies caused fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990, 63:210-216.
57. Blank M., Cohen J., Toder V., et al. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA 2001, 88:3069-3073.
58. Ornoy A., Yacobi S., Matalon S.T., et al. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 2003, 2:573-578.
59. Hanly J.G., Gladman D.D., Rose T.H., et al. Lupus pregnancy. A prospective study of placental changes. Arthritis Rheum 1988, 31:358-366.
60. Nayar R., Lage J.M. Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of literature. Hum Pathol 1996, 27:201-206.
61. Turiel M., Sarzi-Puttini P., Peretti R., et al. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study. Stroke 2005, 36:1490-1494.
62. Gharavi A.E., Pierangeli S.S., Espinola R.G., et al. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells invivo. Arthritis Rheum 2002, 46:545-552.
63. Galli M., Luciani D., Bertolini G., et al. Lupus anticoagulants are stronger riskfactors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003, 101:1827-1832.
64. Peaceman A.M., Rehnberg K.A. The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1993, 169:1403-1406.
65. Cariou R., Tobelem G., Soria C., et al. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. NEngl J Med 1986, 314:1193-1194.
66. Cosgriff T.M., Martin B.A. Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 1981, 24:94-96.
67. Vogt E., Ng A.K., Rote N.S. Amodel for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996, 174:700-707.
68. Robertson S.A., Roberts C.T., van B.E., et al. Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice. Mol Hum Reprod 2004, 10:409-416.
69. Yasuda S., Tsutsumi A., Chiba H., et al. beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis 2000, 152:337-346.
70. Rand J.H., Wu X.X., Quinn A.S., et al. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 2010, 19:460.
71. Rand J.H., Wu X.X., Andree H.A., et al. Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. NEngl J Med 1997, 337:154-160.
72. Out H.J., Bruinse H.W., Christians C.M., et al. Aprospective, controlled multicenter study of the obstetric risks of pregnant women with antiphospholipid antibodies. Br J Obstet Gynaecol 1992, 167:26-32.
73. Salafia C.M., Cowchock F.S. Placental pathology and antiphospholipid antibodies: a descriptive study. Am J Perinatol 1997, 14:435-441.
74. Greaves G., Cohen H., MacHin S.J., et al. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000, 109:704-815.
75. Sebire N.J., Fox H., Backos M., et al. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002, 17:1067-1071.
76. Di Simone N., Caliandro D., Castiellani R., et al. Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999, 14:489-495.
77. Sthoeger Z.M., Mozes E., Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA 1993, 90:6464-6467.
78. Di Simone N., Castellani R., Calandro D., et al. Antiphospholipid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertil Steril 2002, 77:805-811.
79. Tedesco F., Narchi G., Radillo O., et al. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. JImmunol 1993, 151:1562-1570.
80. Girardi G., Berman J., Redecha P., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. JClin Invest 2003, 112:1644-1654.
81. Holers V.M., Girardi G., Mo L., et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. JExp Med 2002, 195:211-220.
82. Salmon J.E., Girardi G. The role of complement in the antiphospholipid syndrome. Curr Dir Autoimmun 2004, 7:133-148.
83. Berman J., Girardi G., Salmon J.E. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody induced pregnancy loss. JImmunol 2005, 174:485-490.
84. Blank M., Krause I., Wildbaum G., et al. TNFα DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. Lupus 2003, 12:546-549.
85. Boles J., Mackman N. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus 2010, 19:370.
86. Alijotas-Reig J., Vilardell-Tarres M. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodiesα. Obstet Gynecol Surv 2010, 65:39-45.
87. Stone S., Pijnenborg R., Vercruysse L., et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006, 27:457-467.
88. Cavazzana I., Nebuloni M., Cetin I., et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory processα. JAutoimmun 2007, 28:160-164.
89. Girardi G., Redecha P., Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004, 10:1222-1226.
90. Di Simone N., Castellani R., Raschi E., et al. Anti-β-2 GPI antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. Ann N Y Acad Sci 2006, 1069:364-376.
91. Di Simone N., Di Nicuolo F., Sarguinetti M., et al. Low-molecular weight heparin induces invitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta 2007, 28:298-304.
92. Ermel L.D., Marshburn P.B., Kutteh W.H. Interaction of heparin with antiphospholipid antibodies (ASA) from the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995, 33:14-20.
93. Franklin R.D., Kutteh W.H. Effects of unfractionated and low molecular weight heparin on antiphospholipid anatibody binding in vitro. Obstet Gynecol 2003, 101:4555-4562.
94. Stephenson M.D., Houlihan E., Tsang P., et al. Concomitant use of IVIG for treatment of the antiphospholipid antibody syndrome (APS) when ASA and heparin results in at least one adverse pregnancy outcome. Lupus 2002, 11:694.
95. Kutteh W.H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584-1589.
96. Stephenson M.D., Ballem P.J., Tsang P., et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. JObstet Gynaecol 2004, 26:729-734.
97. Noble L.S., Kutteh W.H., Lashey N., et al. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin. Fertil Steril 2005, 83:684-690.
98. Erkan D., Merrill J.T., Yazici Y., et al. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001, 44:1466-1467.
99. Hornstein M.D. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 2000, 74(4):635-636.